mondo_id	property	value_old	value_new
MONDO:0000066	label	mitochondrial complex deficiency	mitochondrial respiratory chain complex deficiency
MONDO:0001389	label	congenital coronary artery anomaly	obsolete congenital coronary artery anomaly
MONDO:0005259	label	Asperger syndrome	obsolete Asperger syndrome
MONDO:0007273	label	paragangliomas 4	pheochromocytoma/paraganglioma syndrome 4
MONDO:0007828	label	indifference to pain, congenital, autosomal dominant	obsolete indifference to pain, congenital, autosomal dominant
MONDO:0016195	label	qualitative or quantitative defects of beta-myosin heavy chain (MYH7)	neuromuscular disease caused by qualitative or quantitative defects of beta-myosin heavy chain (MYH7)
MONDO:0008150	label	osteoglophonic dwarfism	osteoglophonic dysplasia
MONDO:0008192	label	paragangliomas 1	pheochromocytoma/paraganglioma syndrome 1
MONDO:0016151	label	qualitative or quantitative defects of perlecan	neuromuscular disease caused by qualitative or quantitative defects of perlecan
MONDO:0009145	label	SchC6pf-Schulz-Passarge syndrome	Sch√∂pf-Schulz-Passarge syndrome
MONDO:0016198	label	qualitative or quantitative defects of plectin	neuromuscular disease caused by qualitative or quantitative defects of plectin
MONDO:0016145	label	qualitative or quantitative defects of dysferlin	neuromuscular disease caused by qualitative or quantitative defects of dysferlin
MONDO:0016153	label	qualitative or quantitative defects of TRIM32	neuromuscular disease caused by qualitative or quantitative defects of TRIM32
MONDO:0016193	label	qualitative or quantitative defects of alpha-actin	neuromuscular disease caused by qualitative or quantitative defects of alpha-actin
MONDO:0016197	label	qualitative or quantitative defects of selenoprotein N1	neuromuscular disease caused by qualitative or quantitative defects of selenoprotein N1
MONDO:0017303	label	qualitative or quantitative defects of tropomyosin	neuromuscular disease caused by qualitative or quantitative defects of tropomyosin
MONDO:0010061	label	autosomal recessive cerebellar ataxia-blindness-deafness syndrome	obsolete autosomal recessive cerebellar ataxia-blindness-deafness syndrome
MONDO:0016147	label	qualitative or quantitative defects of dystrophin	neuromuscular disease caused by qualitative or quantitative defects of dystrophin
MONDO:0010939	label	low phospholipid associated cholelithiasis	gallbladder disease 1
MONDO:0016199	label	qualitative or quantitative defects of protein SERCA1	neuromuscular disease caused by qualitative or quantitative defects of protein SERCA1
MONDO:0011121	label	paragangliomas 2	pheochromocytoma/paraganglioma syndrome 2
MONDO:0016192	label	qualitative or quantitative defects of telethonin	neuromuscular disease caused by qualitative or quantitative defects of telethonin
MONDO:0011544	label	paragangliomas 3	pheochromocytoma/paraganglioma syndrome 3
MONDO:0011627	label	autism, susceptibility to, 5	intellectual developmental disorder with autism and speech delay
MONDO:0013266	label	intellectual disability, autosomal dominant 20	neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language
MONDO:0013546	label	mitochondrial complex V (ATP synthase) deficiency nuclear type 2	mitochondrial complex V (ATP synthase) deficiency, nuclear type 2
MONDO:0013547	label	mitochondrial complex V (ATP synthase) deficiency nuclear type 3	mitochondrial complex V (ATP synthase) deficiency, nuclear type 3
MONDO:0013602	label	paragangliomas 5	pheochromocytoma/paraganglioma syndrome 5
MONDO:0013655	label	intellectual disability, autosomal dominant 8	neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
MONDO:0014091	label	mitochondrial complex V (ATP synthase) deficiency nuclear type 4B	mitochondrial complex V (ATP synthase) deficiency, nuclear type 4B
MONDO:0014453	label	immunodeficiency 36	immunodeficiency 36 with lymphoproliferation
MONDO:0016194	label	qualitative or quantitative defects of nebulin	neuromuscular disease caused by qualitative or quantitative defects of nebulin
MONDO:0018282	label	qualitative or quantitative defects of alpha-dystroglycan	neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan
MONDO:0016186	label	qualitative or quantitative defects of myofibrillar proteins	neuromuscular disease caused by qualitative or quantitative defects of myofibrillar proteins
MONDO:0016191	label	qualitative or quantitative defects of titin	neuromuscular disease caused by qualitative or quantitative defects of titin
MONDO:0018823	label	X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome	obsolete X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome
MONDO:0018825	label	PYCR2-related microcephaly-progressive leukoencephalopathy	obsolete PYCR2-related microcephaly-progressive leukoencephalopathy
MONDO:0020522	label	Ehlers-Danlos syndrome type 7B	obsolete Ehlers-Danlos syndrome type 7B
MONDO:0020732	label	progeria	obsolete progeria
MONDO:0020858	label	mitochondrial complex 5 (ATP synthase) deficiency nuclear type 5	mitochondrial complex V (ATP synthase) deficiency, nuclear type 5
MONDO:0026720	label	mitochondrial complex 1 deficiency, nuclear type 12	mitochondrial complex I deficiency, nuclear type 12
MONDO:0026721	label	mitochondrial complex 1 deficiency, nuclear type 30	mitochondrial complex I deficiency, nuclear type 30
MONDO:0027068	label	mitochondrial complex 1 deficiency, mitochondrial type 1	mitochondrial complex I deficiency, mitochondrial type 1
MONDO:0030902	label	mitochondrial complex 1 deficiency, nuclear type 36	mitochondrial complex I deficiency, nuclear type 36
MONDO:0030997	label	mitochondrial complex 1 deficiency, nuclear type 37	mitochondrial complex I deficiency, nuclear type 37
MONDO:0032606	label	mitochondrial complex 1 deficiency, nuclear type 2	mitochondrial complex I deficiency, nuclear type 2
MONDO:0032608	label	mitochondrial complex 1 deficiency, nuclear type 3	mitochondrial complex I deficiency, nuclear type 3
MONDO:0032609	label	mitochondrial complex 1 deficiency, nuclear type 4	mitochondrial complex I deficiency, nuclear type 4
MONDO:0032610	label	mitochondrial complex 1 deficiency, nuclear type 5	mitochondrial complex I deficiency, nuclear type 5
MONDO:0032611	label	mitochondrial complex 1 deficiency, nuclear type 6	mitochondrial complex I deficiency, nuclear type 6
MONDO:0032612	label	mitochondrial complex 1 deficiency, nuclear type 7	mitochondrial complex I deficiency, nuclear type 7
MONDO:0032613	label	mitochondrial complex 1 deficiency, nuclear type 8	mitochondrial complex I deficiency, nuclear type 8
MONDO:0032615	label	mitochondrial complex 1 deficiency, nuclear type 9	mitochondrial complex I deficiency, nuclear type 9
MONDO:0032616	label	mitochondrial complex 1 deficiency, nuclear type 10	mitochondrial complex I deficiency, nuclear type 10
MONDO:0032617	label	mitochondrial complex 1 deficiency, nuclear type 11	mitochondrial complex I deficiency, nuclear type 11
MONDO:0032618	label	mitochondrial complex 1 deficiency, nuclear type 13	mitochondrial complex I deficiency, nuclear type 13
MONDO:0032619	label	mitochondrial complex 1 deficiency, nuclear type 14	mitochondrial complex I deficiency, nuclear type 14
MONDO:0032620	label	mitochondrial complex 1 deficiency, nuclear type 15	mitochondrial complex I deficiency, nuclear type 15
MONDO:0032621	label	mitochondrial complex 1 deficiency, nuclear type 16	mitochondrial complex I deficiency, nuclear type 16
MONDO:0032622	label	mitochondrial complex 1 deficiency, nuclear type 17	mitochondrial complex I deficiency, nuclear type 17
MONDO:0032623	label	mitochondrial complex 1 deficiency, nuclear type 18	mitochondrial complex I deficiency, nuclear type 18
MONDO:0032624	label	mitochondrial complex 1 deficiency, nuclear type 19	mitochondrial complex I deficiency, nuclear type 19
MONDO:0032625	label	mitochondrial complex 1 deficiency, nuclear type 21	mitochondrial complex I deficiency, nuclear type 21
MONDO:0032626	label	mitochondrial complex 1 deficiency, nuclear type 22	mitochondrial complex I deficiency, nuclear type 22
MONDO:0032627	label	mitochondrial complex 1 deficiency, nuclear type 23	mitochondrial complex I deficiency, nuclear type 23
MONDO:0032628	label	mitochondrial complex 1 deficiency, nuclear type 24	mitochondrial complex I deficiency, nuclear type 24
MONDO:0032629	label	mitochondrial complex 1 deficiency, nuclear type 25	mitochondrial complex I deficiency, nuclear type 25
MONDO:0032630	label	mitochondrial complex 1 deficiency, nuclear type 26	mitochondrial complex I deficiency, nuclear type 26
MONDO:0032631	label	mitochondrial complex 1 deficiency, nuclear type 27	mitochondrial complex I deficiency, nuclear type 27
MONDO:0032632	label	mitochondrial complex 1 deficiency, nuclear type 28	mitochondrial complex I deficiency, nuclear type 28
MONDO:0032633	label	mitochondrial complex 1 deficiency, nuclear type 29	mitochondrial complex I deficiency, nuclear type 29
MONDO:0032634	label	mitochondrial complex 1 deficiency, nuclear type 31	mitochondrial complex I deficiency, nuclear type 31
MONDO:0032635	label	mitochondrial complex 1 deficiency, nuclear type 32	mitochondrial complex I deficiency, nuclear type 32
MONDO:0032636	label	mitochondrial complex 1 deficiency, nuclear type 33	mitochondrial complex I deficiency, nuclear type 33
MONDO:0032756	label	long qt syndrome 8	long QT syndrome 8
MONDO:0032767	label	paragangliomas 6	pheochromocytoma/paraganglioma syndrome 6
MONDO:0032771	label	paragangliomas 7	pheochromocytoma/paraganglioma syndrome 7
MONDO:0032909	label	mitochondrial complex 3 deficiency, nuclear type 10	mitochondrial complex III deficiency, nuclear type 10
MONDO:0032910	label	mitochondrial complex 1 deficiency, nuclear type 34	mitochondrial complex I deficiency, nuclear type 34
MONDO:0033635	label	mitochondrial complex 4 deficiency, nuclear type 3	mitochondrial complex IV deficiency, nuclear type 3
MONDO:0033636	label	mitochondrial complex 4 deficiency, nuclear type 4	mitochondrial complex IV deficiency, nuclear type 4
MONDO:0033637	label	mitochondrial complex 4 deficiency, nuclear type 7	mitochondrial complex IV deficiency, nuclear type 7
MONDO:0033638	label	mitochondrial complex 4 deficiency, nuclear type 8	mitochondrial complex IV deficiency, nuclear type 8
MONDO:0033639	label	mitochondrial complex 4 deficiency, nuclear type 10	mitochondrial complex IV deficiency, nuclear type 10
MONDO:0033645	label	mitochondrial complex 4 deficiency, nuclear type 11	mitochondrial complex IV deficiency, nuclear type 11
MONDO:0033646	label	mitochondrial complex 4 deficiency, nuclear type 12	mitochondrial complex IV deficiency, nuclear type 12
MONDO:0033649	label	mitochondrial complex 4 deficiency, nuclear type 14	mitochondrial complex IV deficiency, nuclear type 14
MONDO:0033650	label	mitochondrial complex 4 deficiency, nuclear type 15	mitochondrial complex IV deficiency, nuclear type 15
MONDO:0033651	label	mitochondrial complex 4 deficiency, nuclear type 16	mitochondrial complex IV deficiency, nuclear type 16
MONDO:0033652	label	mitochondrial complex 4 deficiency, nuclear type 17	mitochondrial complex IV deficiency, nuclear type 17
MONDO:0033653	label	mitochondrial complex 4 deficiency, nuclear type 18	mitochondrial complex IV deficiency, nuclear type 18
MONDO:0033654	label	mitochondrial complex 4 deficiency, nuclear type 19	mitochondrial complex IV deficiency, nuclear type 19
MONDO:0033655	label	mitochondrial complex 4 deficiency, nuclear type 20	mitochondrial complex IV deficiency, nuclear type 20
MONDO:0033656	label	mitochondrial complex 4 deficiency, nuclear type 21	mitochondrial complex IV deficiency, nuclear type 21
MONDO:0100503	label	DPH5-related diphthamide-deficiency syndrome	obsolete DPH5-related diphthamide-deficiency syndrome
MONDO:0700299	label	ACTH-independent macronodular adrenal hyperplasia-3	ACTH-independent macronodular adrenal hyperplasia 3
MONDO:0850090	label	fibrosis-neurodegeneration-cerebral angiomatosis syndrome	obsolete fibrosis-neurodegeneration-cerebral angiomatosis syndrome
MONDO:0859321	label	mitochondrial complex 3 deficiency, nuclear type 11	mitochondrial complex III deficiency, nuclear type 11
MONDO:0859761	label	SLC12A2-related autosomal recessive neonatal-developmental delay-intellectual disability-feeding difficulty-sensorineural deafness syndrome	obsolete SLC12A2-related autosomal recessive neonatal-developmental delay-intellectual disability-feeding difficulty-sensorineural deafness syndrome
MONDO:0859762	label	SLC12A2-related autosomal dominant infantile-developmental delay-intellectual disability-sensorineural deafness syndrome	obsolete SLC12A2-related autosomal dominant infantile-developmental delay-intellectual disability-sensorineural deafness syndrome
MONDO:0957115	label	neurological muscular channelopathy due to a genetic ryanodine receptor defect	obsolete neurological muscular channelopathy due to a genetic ryanodine receptor defect
MONDO:0000066	definition		A mitochondrial energy metabolism disorder where respiratory complex (I‚ÄìV) is dysfunctional, typically due to mutations in genes encoding that specific complex‚Äôs proteins or assembly factors.
MONDO:0000358	definition		A disorder of facial skeleton that is characterized by cleft lip and/or cleft palate that result in feeding, speech and hearing problems caused by failures during development.
MONDO:0015203	definition		A coronary artery disorder characterized by abnormal origin, course, or structure of one or more coronary arteries present at birth.
MONDO:0017623	definition	A group of clinically heterogeneous disorders united by a germline PTEN mutation and the involvement of derivatives of all 3 germ cell layers, manifesting with hamartomas, overgrowth and neoplasia. Currently, subsets carrying clinical diagnoses of Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Proteus and Proteus-like syndromes and SOLAMEN syndrome belong to PHTS.	An autosomal dominant syndrome caused by pathogenic variants in the PTEN gene, characterized by hamartomas, overgrowth, neurodevelopmental disorders and an increased risk of various cancers, including breast, thyroid, and endometrial cancer. PHTS encompasses Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, and Proteus-like syndrome.
MONDO:0005311	definition	Build-up of fatty material and calcium deposition in the arterial wall resulting in partial or complete occlusion of the arterial lumen.	A disease characterized by the build-up of fatty material and calcium deposition in the arterial wall resulting in partial or complete occlusion of the arterial lumen.
MONDO:0018160	definition	An inherited malignant tumor that originates in the nuclear layer of the retina. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.	An autosomal dominant disorder caused by pathogenic variants in the RB1 gene, characterized by an increased risk of retinoblastoma in early childhood. Individuals with hereditary retinoblastoma also have an increased risk of developing secondary cancers, such as osteosarcoma, melanoma and carcinomas in childhood and adulthood.
MONDO:0008679	definition		An autosomal disorder due to pathogenic variants in the WT1 gene leading to an increased risk Wilms tumor and genitourinary abnormalities incorporating Denys-Drash syndrome and Frasier syndrome.
MONDO:0008667	definition	A familial cancer predisposition syndrome associated with a variety of malignant and benign neoplasms, most frequently retinal, cerebellar, and spinal hemangioblastoma, renal cell carcinoma (RCC), and pheochromocytoma.	An autosomal dominant disorder caused by pathogenic variants in the VHL gene, leading to an increased risk of various benign and malignant tumors, including hemangioblastomas, retinal hemangiomas, endolymphatic sac tumors, renal cell carcinoma, and pheochromocytomas.
MONDO:0005259	definition	A disorder most often diagnosed in the pediatric years in which the individual displays marked impairment in social interaction and a repetitive, stereotyped pattern of behavior. The individual, however, displays no delay in language or cognitive development, which differentiates Asperger Syndrome from autism.	
MONDO:0018630	definition	Hereditary nonpolyposis colon cancer (HNPCC) is a cancer-predisposing condition characterized by the development of colorectal cancer not associated with colorectal polyposis, endometrial cancer, and various other cancers (such as malignant epithelial tumor of ovary, gastric, biliary tract, small bowel, and urinary tract cancer) that are frequently diagnosed at an early age.	A cancer-predisposing condition characterized by the development of colorectal cancer not associated with colorectal polyposis, endometrial cancer, and various other cancers (such as malignant epithelial tumor of ovary, gastric, biliary tract, small bowel, and urinary tract cancer) that are frequently diagnosed at an early age.
MONDO:0005868	definition	A laboratory test result indicating an abnormal amount of circulating nucleated red blood cells and immature red blood cells.	An aplastic anemia that is characterized by displacement of hemopoietic bone-marrow tissue either by fibrosis, tumors or granulomas.
MONDO:0008280	definition	Peutz-Jeghers syndrome (PJS) is an inherited gastrointestinal disorder characterized by development of characteristic hamartomatous polyps throughout the gastrointestinal (GI) tract, and by mucocutaneous pigmentation. PJS carries a considerably increased risk of GI and extra-GI malignancies.	An autosomal dominant disorder caused by pathogenic variants in the STK11 gene, characterized by hamartomatous polyps in the gastrointestinal tract, mucocutaneous pigmentation and increased risk of GI and extra-GI malignancies.
MONDO:0012672	definition	The presence of calculi in the gallbladder.	The presence of crystallized deposits forming in the gallbladder or biliary tree, primarily composed of cholesterol, bilirubin, and bile.
MONDO:0020528	definition	Adrenocorticotropic hormone dependent Cushing syndrome (ACTH-dependent CS) is a form of endogenous CS caused by abnormal production of ACTH due, in 80% of cases, to ACTH oversecretion by a pituitary adenoma (Cushing disease, CD) and in 20% of cases to ectopic ACTH secretion (CS due to EAS) by an extrapituitary tumor (in 50% of cases originating in the lungs or less commonly in the thymus, pancreas, adrenal gland or thyroid) or very rarely due to a tumor secreting both ACTH and corticotrophin-releasing hormone (CRH).	A group of endogenous Cushing syndrome caused by abnormal production of ACTH due to pituitary adenoma or an extrapituitary tumor.
MONDO:0007273	definition	Any paraganglioma in which the cause of the disease is a mutation in the SDHB gene.	An autosomal dominant tumor predisposition disorder caused by pathogenic variants in the SDHB gene, characterized by an increased risk of paraganglioma and pheochromocytoma, as well as an increased risk of renal cell carcinoma and gastrointestinal stromal tumors (GIST).
MONDO:0017366	definition	Hereditary paraganglioma-pheochromocytomas (PGL/PCC) are rare neuroendocrine tumors represented by paragangliomas (occurring in any paraganglia from the skull base to the pelvic floor) and pheochromocytomas (adrenal medullary paragangliomas).	Neoplasm predisposition characterized by an increased risk of paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla).
MONDO:0009509	definition	Landau-Kleffner syndrome (LKS) is a rare neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and recurrent seizures (epilepsy). Children with LKS typically develop normally until signs and symptoms of the syndrome begin to develop between age 2 and 8 years. Males are more often affected by LKS than females. In about 20% of people with LKS, mutations (changes) in the GRIN2A gene have been identified. The syndrome is inherited in an autosomal dominant manner. In other cases, the syndrome may be caused by changes to other unidentified genes. LKS is diagnosed when a doctor sees clinical features that are consistent with the syndrome such as a loss of speech and an electroencephalogram (EEG) that shows specific kinds of seizure activity. Genetic testing can be used to confirm if there is a mutation in GRIN2A, but this testing is not done routinely. Treatment for LKS usually consists of medications such as anticonvulsants and corticosteroids to help prevent seizures. Speech therapy should also be started promptly in order to ensure the best long-term outlook for children with LKS.	A rare form of epileptic encephalopathy with spike-wave activation in sleep (EE-SWAS) characterized by various combinations of acquired cognitive, language, behavioral, and motor deficits associated with marked spike- and- wave activation in sleep. In Landau-Kleffner syndrome, receptive language is mainly affected, with an acquired auditory verbal agnosia.
MONDO:0007356	definition	Any Lynch syndrome in which the cause of the disease is a mutation in the MSH2 gene.	An autosomal dominant hereditary neoplastic syndrome caused by pathogenic variants in the MSH2 mismatch repair gene. It is characterized by an increased risk of colorectal cancer in the absense of extensive polyposis, endometrial, ovarian, gastric, small intestinal, and urinary tract cancers, often occuring at younger ages.
MONDO:0015448	definition	Isolated complex III deficiency is a rare, genetic, mitochondrial oxidative phosphorylation disorder characterized by a wide spectrum of clinical manifestations ranging from isolated myopathy or transient hepatopathy to severe multisystem disorder (that may include hypotonia, failure to thrive, psychomotor delay, cardiomyopathy, encephalopathy, renal tubulopathy, hearing impairment, lactic acidosis, hypoglycemia and other signs and symptoms).	A rare, genetic, mitochondrial oxidative phosphorylation disorder characterized by a wide spectrum of clinical manifestations ranging from isolated myopathy or transient hepatopathy to severe multisystem disorder (that may include hypotonia, failure to thrive, psychomotor delay, cardiomyopathy, encephalopathy, renal tubulopathy, hearing impairment, lactic acidosis, hypoglycemia and other signs and symptoms).
MONDO:0007540	definition	Multiple endocrine neoplasia Type 1 (MEN1) is a frequent form of MEN, a rare inherited cancer syndrome, characterized by the development of neuroendocrine tumors of the parathyroid, pancreas, and anterior pituitary gland, and less commonly the adrenal cortical gland, with other non-endocrine tumors in some patients.	An autosomal dominant tumor predisposition syndrome caused by pathogenic variants in the MEN1 gene, characterized by an increased risk of tumors of the parathyroid glands, pituitary gland, and foregut neuroendocrine tumors (most commonly pancreatic islet cells).
MONDO:0007798	definition	OBSOLETE. Adult hypophosphatasia (A-HPP) is a mildform of hypophosphatasia characterized by osteomalacia, chondrocalcinosis, osteoarthropathy, stress fractures duringmiddle age, and dental anomalies.	
MONDO:0958106	definition		A pain insensitivity disorder in which the cause of the disease is a mutation in ZFHX2 gene. It is characterized by a lowered ability to sense pain, to experience temperature, and to sweat.
MONDO:0018875	definition	A rare cancer predisposition syndrome characterized by the early-onset of multiple primary cancers such as breast cancer, soft tissue and bone sarcomas, brain tumors and adrenal cortical carcinoma (ACC).	An autosomal dominant cancer predisposition disorder caused by pathogenic variants in the TP53 gene, characterized by an increased risk of a wide range of cancers, including but not limited to breast cancer, soft tissue sarcomas, osteosarcomas, brain tumors, adrenocortical carcinoma and leukemias.
MONDO:0007983	definition	Schmid metaphyseal chondrodysplasia is a rare disorder characterized by moderately short stature with short limbs, coxa vara, bowlegs and an abnormal gait.	A rare skeletal disorder caused by a variation in COL10A1 gene and is characterized by moderately short stature with short limbs, coxa vara, bowlegs and an abnormal gait.
MONDO:0008082	definition	Multiple endocrine neoplasia 2B (MEN2B) syndrome is a rare aggressive form of MEN2 characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, mucosal ganglioneuroma, and marfanoid habitus.	An autosomal dominant disorder caused by specific pathogenic variants in the RET gene, characterized by an increased risk of very early onset medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism, and mucosal neuromas.
MONDO:0008150	definition	Osteoglophonic dwarfism (OGD) is characterized by dwarfism, severe craniofacial abnormalities and multiple unerupted teeth.	A rare skeletal disorder characterized by dwarfism, severe craniofacial abnormalities and multiple unerupted teeth.
MONDO:0008192	definition	Any paraganglioma in which the cause of the disease is a mutation in the SDHD gene.	An autosomal dominant tumor predisposition disorder caused by pathogenic variants in the SDHD gene, characterized by an increased risk of paraganglioma and pheochromocytoma, as well as an increased risk of renal cell carcinoma and gastrointestinal stromal tumors (GIST).
MONDO:0008206	definition	Benign paroxysmal tonic upgaze of childhood with ataxia is a rare paroxysmal movement disorder characterized by episodes of sustained, conjugate, upward deviation of the eyes and down beating saccades in attempted downgaze (with preserved horizontal eye movements) which is accompanied by ataxic symptomatology (unsteady gait, lack of balance and movement coordination disturbances) in an otherwise healthy individual. Bilateral vertical nystagmus is associated. Symptoms generally disappear spontaneously within 1-2 years after onset.	A rare paroxysmal movement disorder characterized by episodes of sustained, conjugate, upward deviation of the eyes and down beating saccades in attempted downgaze (with preserved horizontal eye movements) which is accompanied by ataxic symptomatology (unsteady gait, lack of balance and movement coordination disturbances) in an otherwise healthy individual. Bilateral vertical nystagmus is associated. Symptoms generally disappear spontaneously within 1-2 years after onset.
MONDO:0008234	definition	Multiple endocrine neoplasia 2A (MEN2A) syndrome is a form of MEN2 characterized by medullary thyroid carcinoma (MTC) in combination with pheochromocytoma and primary mild hyperparathyroidism resulting from hyperplasia or adenoma of the parathyroid cells.	An autosomal dominant tumor predisposition disorder caused by pathogenic variants in the RET gene, characterized by an increased risk of medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism.
MONDO:0008272	definition	Polysyndactyly or PPD4 is a form of preaxial polydactyly of fingers, a limb malformation syndrome, characterized by the presence of a thumb showing the mildest degree of duplication, being broad, bifid or with radially deviated distal phalanx. Syndactyly of various degrees of third-and-fourth fingers is occasionally present.	Preaxial polydactyly characterized by the presence of a thumb showing the mildest degree of duplication, being broad, bifid or with radially deviated distal phalanx, occasional syndactyly of various degrees of third-and-fourth fingers, and duplication of part or all of the first or second toes and syndactyly.
MONDO:0008278	definition		An autosomal dominant syndrome caused by pathogenic variants in the SMAD4 gene, characterized by the combined features of juvenile polyposis syndrome (JPS) and hereditary hemorrhagic telangiectasia (HHT). JPS features include multiple juvenile polyps in the gastrointestinal tract and an increased risk of gastrointestinal cancers. HHT features include arteriovenous malformations (AVMs) and telangiectasias.
MONDO:0008478	definition	Spondylometaphyseal dysplasia, Schmidt type is characterized by short stature, myopia, small pelvis, progressive kypho-scoliosis, wrist deformity, severe genu valgum, short long bones, and severe metaphyseal dysplasia with moderate spinal changes and minimal changes in the hands and feet.	A spondylometaphyseal dysplasia caused by a variation in COL2A1 gene. It is characterized by short stature, myopia, small pelvis, progressive kypho-scoliosis, wrist deformity, severe genu valgum, short long bones, and severe metaphyseal dysplasia with moderate spinal changes and minimal changes in the hands and feet.
MONDO:0008612	definition	Tuberous sclerosis mapped to chromosome 9q34 (TSC1 gene).	An autosomal dominant syndrome caused by pathogenic variants in the TSC1 gene, characterized by the growth of hamartomas in multiple organs, including the brain, skin, kidneys, heart, and lungs. Other clinical features include seizures, intellectual disability, and skin lesions.
MONDO:0020529	definition	Adrenocorticotropic hormone (ACTH) independent Cushing syndrome is a form of endogenous Cushing syndrome (CS) that may result from excess secretion of cortisol by either a unilateral and benign (adrenocortical adenoma: 55-60%) or malignant (adrenocortical carcinoma: 35-40 %) adrenocortical tumor or by bilateral adrenal secretion by macronodular adrenal hyperplasia (AIMAH), as an isolated disease or as part of McCune-Albright syndrome (MAS), or by primary pigmented nodular adrenocortical disease (PPNAD), as an isolated disease or as part of Carney complex (CNC).	A group of endogenous Cushing syndrome  that may result from excess secretion of cortisol by either a unilateral and benign, or malignant adrenocortical tumor, or nodular adrenocortical disease.
MONDO:0009050	definition	Cushing's syndrome due to abnormally high secretion of adrenocorticotropic hormone (ACTH) from the pituitary gland.	A form of adrenocorticotropic hormone (ACTH)-dependent Cushing syndrome, an endogenous Cushing syndrome (CS), characterized by chronic over-secretion of adrenocorticotropic hormone (ACTH) due to a pituitary corticotroph adenoma.
MONDO:0009427	definition	OBSOLETE. Infantile hypophosphatasia (I-HPP) is a very rare, severe form of hypophosphatasia characterized by infantile rickets without elevated serum alkaline phosphatase (ALP) activity and a wide range of clinical manifestations due to hypomineralization.	
MONDO:0009428	definition	OBSOLETE. Childhood-onset hypophosphatasia is a rare, mildform of hypophosphatasia characterized by onset after six months of age and widely variable clinical features from low bone mineral density for age, to unexplained fractures,skeletal deformities,and rickets with short stature and waddling gait.	
MONDO:0100223	definition		Any mitochondrial complex I deficiency in which the cause of the disease is a mutation in the nuclear-encoded genes that encode structural subunits or assembly factors of complex I.
MONDO:0010026	definition	SHORT syndrome is a rare inherited condition of multiple anomalies whose name stands for short stature, hyperextensibility of joints, ocular depression, Rieger anomaly and teething delay which, along with mild intrauterine growth restriction, partial lipodystrophy, delayed bone age, hernias and progeroid appearance, are manifestations of the disease.	A rare disorder characterized by multiple congenital anomalies, including short stature, hyperextensibility of joints, ocular depression, Rieger anomaly and teething delay in which the cause of the disease is a mutation in PIK3R1 gene. Other common manifestations of SHORT syndrome are mild intrauterine growth restriction, partial lipodystrophy, delayed bone age, hernias and a recognizable facial gestalt.
MONDO:0013931	definition		Any peroxisome biogenesis disorder due to PEX6 defect characterized by the association of early-onset cerebellar ataxia with hearing loss and blindness. Patients may also present demyelinating peripheral motor neuropathy. Cerebral MRI shows alterations of the cerebellar white matter without cerebellar atrophy.
MONDO:0010159	definition	A rare childhood cancer predisposition syndrome caused by biallelic inheritance of mutations in MLH1, MSH2, MSH6, or PMS2 genes. It is characterized by the development of childhood cancers, usually hematological malignancies and/or brain tumors, and colorectal cancers with multiple intestinal polyps. The majority of patients show signs of neurofibromatosis type 1.	An autosomal recessive constitutional mismatch repair deficiency syndrome caused by pathogenic variants in the MLH1 mismatch repair gene. It is characterized by a high risk of childhood cancers, including hematological malignancies and brain tumors, as well as colorectal cancers with polyposis.
MONDO:0031219	definition		A rare childhood cancer predisposition syndrome caused by biallelic inheritance of mutations in MLH1, MSH2, MSH6, or PMS2 genes. It is characterized by the development of childhood cancers, usually hematological malignancies and/or brain tumors, and colorectal cancers with multiple intestinal polyps. The majority of patients show signs of neurofibromatosis type 1.
MONDO:0020070	definition		An epilepsy syndrome that has an onset during the neonatal stage of life.
MONDO:0016980	definition		A X-linked intellectual disability characterized by distinctive craniofacial features, genital anomalies, hypotonia, and mild-to-profound developmental delay/intellectual disability.
MONDO:0010561	definition	A rare genetic neurological disorder characterized by psychomotor and growth retardation, facial dysmorphism, digit abnormalities, and progressive skeletal changes.	A rare X-linked syndromic intellectual disability characterized by global development delay, postnatal growth retardation leading to short stature, facial dysmorphism, short hands with tapering fingers and progressive skeletal abnormalities including kyphoscoliosis and pectus carinatum/excavatum. Intellectual disability ranges from mild to severe.
MONDO:0010778	definition	A rare abnormality of the neuroendocrine system that is characterized by episodic nausea and vomiting.	A rare functional disorder characterized by recurrent, stereotypical episodes of severe nausea and vomiting separated by symptom-free intervals. Episodes are often accompanied by pallor, lethargy, and abdominal pain. The condition shows a strong association with migraine headaches and may have maternal inheritance patterns suggestive of mitochondrial involvement.
MONDO:0010939	definition	Low phospholipid associated cholelithiasis is a rare genetic hepatic disease characterized by cholesterol gallstones and intrahepatic stones developing before the age of 40 years.	A rare genetic hepatic disease characterized by low biliary phospholipid concentration with symptomatic and recurring cholelithiasis which develops before the age of 40 years.
MONDO:0010945	definition	Any retinitis pigmentosa in which the cause of the disease is a mutation in the CA4 gene.	Any retinitis pigmentosa caused by duplication or triplication in the chromosome 17q22-q23 region that results in disruption of topologically associated domains (TADs) and increased retinal expression of GDPD1.
MONDO:0011121	definition	Any paraganglioma in which the cause of the disease is a mutation in the SDHAF2 gene.	An autosomal dominant tumor predisposition disorder caused by pathogenic variants in the SDHAF2 gene, characterized by an increased risk of paraganglioma, particularly head and neck paragangliomas.
MONDO:0011544	definition	Any paraganglioma in which the cause of the disease is a mutation in the SDHC gene.	An autosomal dominant tumor predisposition disorder caused by pathogenic variants in the SDHC gene, characterized by an increased risk of paraganglioma and pheochromocytoma, as well as an increased risk of renal cell carcinoma and gastrointestinal stromal tumors (GIST).
MONDO:0011577	definition		Any congenital myopathy in which the cause of the disease is a mutation in MYH2 gene. The disorder is either slowly progressive or nonprogressive, and affected individuals retain ambulation, although there is variable severity. It can show both autosomal dominant and autosomal recessive inheritance.
MONDO:0011627	definition		A neurodevelopmental disorder caused by the mutation in the TBR1 gene and characterized by varying degrees of intellectual disability, autism spectrum disorder, and language deficits.
MONDO:0012041	definition	An autosomal recessive hereditary neoplastic syndrome caused by mutations in the MUTYH gene on chromosome 1p34.1. It is characterized by the presence of multiple colorectal polyps that may progress to carcinoma. Development of gastric and small intestinal polyps may also occur.	An autosomal recessive hereditary cancer predisposition disorder caused by pathogenic variants in the MUTYH gene. It is characterized by an increased risk of colorectal adenomatous polyposis and carcinomas.
MONDO:0012249	definition	Any hereditary nonpolyposis colon cancer in which the cause of the disease is a mutation in the MLH1 gene.	An autosomal dominant hereditary neoplastic syndrome caused by pathogenic variants in the MLH1 mismatch repair gene. It is characterized by an increased risk of colorectal cancer in the absence of extensive polyposis, endometrial, ovarian, gastric, small intestinal, and urinary tract cancers, often occurring at younger ages.
MONDO:0013452	definition	Multisystemic smooth muscle dysfunction syndrome is a disease in which the activity of smooth muscle throughout the body is impaired. This leads to widespread problems including blood vessel abnormalities, a decreased response of the pupils to light, a weak bladder, and weakened contractions of the muscles used for the digestion of food (hypo peristalsis). A certain mutation in the ACTA2 gene has been shown to cause this condition insome individuals.	A spectrum of conditions caused by monoallelic pathogenic variants in ACTA2. Phenotypes can present in isolation or in combination and can include, but are not limited to: cardiovascular manifestations (heritable thoracic aortic aneurysm and dissection, coronary artery disease, patent ductus arteriosus, aortic pulmonary window, and/or early-onset atherosclerosis), smooth muscle cell dysfunction (hypoperistalsis, hydronephrosis and hydroureter, megacystis), ophthalmological manifestations (retinal vessel disease, congenital mydriasis and iris flocculi/hypoplasia), and a Moyamoya-like cerebrovascular disease.
MONDO:0012992	definition	This syndrome is characterized by exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis.	A rare syndromic mitochondrial disease in which the cause of the disease is a mutation in the COX4I2 gene. It is characterized by exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis.
MONDO:0013196	definition	Any hereditary nonpolyposis colon cancer in which the cause of the disease is a mutation in the EPCAM gene.	Any hereditary nonpolyposis colon cancer in which the cause of the disease is a  heterozygous deletion of 3-prime exons of the EPCAM gene and intergenic regions directly upstream of the MSH2 gene, resulting in transcriptional read-through and epigenetic silencing of MSH2 in tissues expressing EPCAM.
MONDO:0013199	definition	Tuberous sclerosis mapped to chromosome 16p13.3 (TSC2 gene).	An autosomal dominant syndrome caused by pathogenic variants in the TSC2 gene, characterized by the growth of hamartomas in multiple organs, including the brain, skin, kidneys, heart, and lungs. Other clinical features include seizures, intellectual disability, and skin lesions.
MONDO:0013546	definition	A mitochondrial complex deficiency characterized by early neonatal onset of hypotonia, hypetrophic cardiomyopathy and apneic spells within hours after birth accompanied by lactic acidosis, hyperammonemia and 3-methylglutaconic aciduria.	Any mitochondrial complex deficiency in which the cause of the disease is a mutation in the TMEM70 gene. It is characterized by early neonatal onset of hypotonia, hypetrophic cardiomyopathy and apneic spells within hours after birth accompanied by lactic acidosis, hyperammonemia and 3-methylglutaconic aciduria.
MONDO:0013699	definition	Any hereditary nonpolyposis colon cancer in which the cause of the disease is a mutation in the PMS2 gene.	An autosomal dominant hereditary neoplastic caused by pathogenic variants in the PMS2 mismatch repair gene. It is characterized by an increased risk of colorectal cancer in the absence of extensive polyposis, endometrial, ovarian, gastric, small intestinal, and urinary tract cancers.
MONDO:0013710	definition	Any hereditary nonpolyposis colon cancer in which the cause of the disease is a mutation in the MSH6 gene.	An autosomal dominant hereditary neoplastic syndrome caused by pathogenic variants in the MSH6 mismatch repair gene. It is characterized by an increased risk of colorectal cancer in the absence of extensive polyposis, endometrial, ovarian, gastric, small intestinal, and urinary tract cancers, often occuring at younger ages.
MONDO:0014453	definition		A primary immunodeficiency disease in which the cause of the disease is a mutation in PIK3R1 gene. It is characterized by infantile or childhood onset of recurrent bacterial respiratory tract infections, lymphoproliferation, variable antibody deficiency (sometimes with hyper IgM), chronic viral infection (EBV, CMV), and autoimmunity.
MONDO:0021056	definition	Any attenuated familial adenomatous polyposis in which the cause of the disease is a mutation in the APC gene.	An autosomal dominant disorder caused by pathogenic variants in the APC gene, characterized by the development of colorectal adenomatous polyposis, a very high risk of colorectal cancer and other extracolonic manifestations including both classic and attenuated familial adenomatous polyposis (FAP).
MONDO:0016862	definition		Any Alagille syndrome due to a variation in the JAG1 gene that affects many organ systems including the liver, heart, skeleton, eyes and kidneys.
MONDO:0017325	definition	Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation is a rare intellectual disability and epilepsy syndrome characterized by global developmental delay and mild to profound intellectual disability, multiple types of usually intractable focal and generalized seizures with variable abnormal EEG findings, and bilateral progressive parenchymal volume loss and thin corpus callosum on brain MRI.	A rare intellectual disability and epilepsy syndrome due to mutation in GRIN2A gene. It is characterized by global developmental delay and mild to profound intellectual disability, multiple types of usually intractable focal and generalized seizures with variable abnormal EEG findings, and bilateral progressive parenchymal volume loss and thin corpus callosum on brain MRI.
MONDO:0017790	definition	A rare hereditary gastric cancer characterized by proximal gastric polyposis and increased risk of early-onset, intestinal-type adenocarcinoma of the gastric body, with no duodenal or colorectal polyposis. This is an n-of-1 use case where only one patient or family has been described with this disorder.	An autosomal dominant disorder caused by specific pathogenic variants in the APC gene promoter, characterized by proximal gastric polyposis and an increased risk of gastric adenocarcinoma.
MONDO:0018206	definition		A rare, genetic, non-dystrophic myopathy disease characterized by childhood-onset severe external ophthalmoplegia, typically without ptosis, associated with mild, very slowly progressive muscular weakness and atrophy, involving the facial, neck flexor and limb (upper > lower, proximal > distal) muscles. Muscle biopsy shows type 1 fiber uniformity, absent, or abnormally small, type 2A fibers, increased variability of fiber size, internalized nuclei and/or fatty infiltration.
MONDO:0018806	definition		A rare biliary tract disease characterized by stone formation within the intrahepatic bile ducts without any known cause, leading to bile stasis and repeated cholangitic episodes.
MONDO:0018825	definition	PYCR2-related microcephaly-progressive leukoencephalopathy is a rare, genetic, syndromic intellectual disability disorder characterized by progressive postnatal microcephaly, cerebral hypomyelination and severe psychomotor developmental delayed with absent speech, as well as axial hypotonia, appendicular hypertonia with hyperextensibility of the wrists and ankles, hyperreflexia, severe muscle wasting and failure to thrive. Associated craniofacial dysmorphism includes triangular facies with bitemporal narrowing, down- or upslanting palpebral fissures, malar hypoplasia, large malformed ears with overfolded helices, upturned bulbous nose, long smooth philtrum and thin vermilion borders.	
MONDO:0019195	definition	Hereditary inclusion body myopathy type 3 is characterized by congenital joint contractures (normalizing during early childhood), external ophthalmoplegia, and proximal muscle weakness. In adult cases, the muscular weakness is progressive.	A rare genetic neuromuscular disease characterized by early onset of proximal or generalized muscle weakness, external ophthalmoplegia with or without ptosis, and joint contractures. Hypotonia, neonatal respiratory distress necessitating ventilation, and severe dysphagia have also been reported. The disease is of variable severity and non- or slowly progressive. Patients typically remain ambulatory. Muscle biopsy may show predominance of type 1 fibers, marked variability in fiber size, increased internal nuclei, and proliferation of perimysial and endomysial connective tissue.
MONDO:0019504	definition	Superior limbic keratoconjunctivitis (SLK) is a chronic and recurrent eye disease which affects thesuperior bulbar conjunctiva (the clear layer that covers the eyeball, over the sclera) and tarsal conjunctiva (the clear layer that lines the eyelids), as well as the superior limbic aspect of the cornea (the area above the cornea). It is commonly found in women 20-70 years of age. The signs and symptoms include burning, redness and irritation and tend to develop slowly over a period of 1 to 10 years.Vision usually remains intact. While the underlying cause ofSLK remains unknown, it is believed that the condition issecondary to superior bulbar conjunctiva laxity. Factors inducing conjunctiva laxity include thyroid eye disease (usually hyperthyroidism), tight upper eyelids, and prominent globes. A mimicking disorder has been encountered in soft contact lens (SCL) wearers, typically with exposure to thimerosal-preserved solutions. Treatment of SLK may involve the use of various medications, surgery, or a combination of both.	A chronic and recurrent eye disease which affects the superior bulbar conjunctiva (the clear layer that covers the eyeball, over the sclera) and tarsal conjunctiva (the clear layer that lines the eyelids), as well as the superior limbic aspect of the cornea (the area above the cornea). It is commonly found in women 20-70 years of age. The signs and symptoms include burning, redness and irritation and tend to develop slowly over a period of 1 to 10 years.Vision usually remains intact. While the underlying cause of SLK remains unknown, it is believed that the condition is secondary to superior bulbar conjunctiva laxity. Factors inducing conjunctiva laxity include thyroid eye disease (usually hyperthyroidism), tight upper eyelids, and prominent globes. A mimicking disorder has been encountered in soft contact lens (SCL) wearers, typically with exposure to thimerosal-preserved solutions. Treatment of SLK may involve the use of various medications, surgery, or a combination of both.
MONDO:0020527	definition	Cushing syndrome due to ectopic (adrenocorticotropic hormone) ACTH secretion (EAS) is a form of ACTH-dependent Cushing syndrome caused by excess secretion of ACTH by a benign or, more often, malignant non-pituitary tumor.	A form of ACTH-dependent Cushing syndrome caused by excess secretion of ACTH by a benign or, more often, malignant non-pituitary tumor.
MONDO:0957431	definition		Any Cushing syndrome caused by body's prolonged overproduction of cortisol that can be dependent on or independent of adrenocorticotropic hormone (ACTH).
MONDO:0020735	definition		Any Cushing syndrome due to macronodular adrenal hyperplasia in which the cause of the disease is a mutation in the GNAS1 gene.
MONDO:0020858	definition		Any mitochondrial complex deficiency in which the cause of the disease is a mutation in the ATP5F1D gene.
MONDO:0027068	definition	Any mitochondrial complex 1 deficiency, mitochondrial type 1, in which the cause of the disease is a mutation in the MTND3 gene.	Any mitochondrial complex I deficiency, mitochondrial type, in which the cause of the disease is a mutation in the MTND3 gene.
MONDO:0100134	definition		Any mitochondrial complex I deficiency in which the cause of the disease is a mitochondrial mutation in the complex I subunit genes.
MONDO:0030309	definition		A form of mitochondrial disease that is caused by biallelic (autosomal recessive) mutations in nuclear‚Äëencoded genes normally associated with mitochondrial Complex I subunits or assembly factors. It is characterized by sudden, painless central vision loss, optic nerve microangiopathy, and eventual atrophy in the absence of mtDNA mutations.
MONDO:0030831	definition		A rare hereditary disease characterized by intestinal obstruction and profound combined immune deficiency.
MONDO:0030840	definition		An autosomal recessive constitutional mismatch repair deficiency syndrome caused by pathogenic variants in the MSH2 mismatch repair gene. It is characterized by a high risk of many different types of childhood cancers, including hematological malignancies, brain tumors, intestinal polyposis, and colon cancer.
MONDO:0030841	definition		An autosomal recessive constitutional mismatch repair deficiency syndrome caused by pathogenic variants in the MSH6 mismatch repair gene is characterized by a high risk of childhood cancers, including hematological malignancies, brain tumors, and colorectal
MONDO:0030843	definition		An autosomal recessive constitutional mismatch repair deficiency syndrome caused by pathogenic variants in the PMS2 mismatch repair gene. It is characterized by a high risk of childhood cancers, including hematological malignancies and brain tumors, as well as colorectal cancers with polyposis.
MONDO:0030937	definition		A an autosomal recessive caused by pathogenic variants in the SDHD gene, leading to dysfunction of mitochondrial complex II. Clinical features are variable and may include Leigh syndrome, cardiomyopathy, and other neurological and muscular manifestations.
MONDO:0030974	definition		An autosomal recessive disorder due to pathogenic variants in the SDHB gene, resulting in Mitochondrial complex II deficiency and a variety of clinical manifestations, including neurological and muscular symptoms.
MONDO:0032651	definition		Any syndromic disease caused by a mutation in the NHLRC2 gene and is characterized by severe progressive cerebropulmonary symptoms, resulting in death in infancy from respiratory failure. Features include malabsorption, progressive growth failure, recurrent infections, chronic hemolytic anemia, and transient liver dysfunction.
MONDO:0032909	definition		Any mitochondrial complex deficiency in which the cause of the disease is a mutation in the UQCRFS1 gene.
MONDO:0033635	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX10 gene.
MONDO:0033636	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the SCO1 gene.
MONDO:0033637	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX6B1 gene.
MONDO:0033638	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the TACO1 gene.
MONDO:0033639	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX14 gene.
MONDO:0033645	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX20 gene.
MONDO:0033646	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the PET100 gene.
MONDO:0033649	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COA3 gene.
MONDO:0033650	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX8A gene.
MONDO:0033651	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX4I1 gene.
MONDO:0033652	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COA8 gene.
MONDO:0033653	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX6A2 gene.
MONDO:0033654	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the PET117 gene. It is characterized by the onset of symptoms in infancy or early childhood. Affected individuals show global developmental delay and developmental regression with a loss of acquired motor and language skills. Additional features include motor dysfunction, such as hypokinesia and pyramidal signs. More variable features may include recurrent infections with immunodeficiency and possibly protein-losing enteropathy.
MONDO:0033655	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX5A gene.
MONDO:0033656	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COXFA4 gene.
MONDO:0033667	definition		Any neurodevelopmental disorder in which the cause of the disease is a mutation in the SLC12A2 gene. It is characterized by global developmental delay, mild to moderate intellectual disability, delayed, poor or absent speech, hypotonia with delayed or absent walking, bilateral sensorineural deafness, and autistic features. Variable features may include ventricular septal defect, tracheoesophageal fistula, hip dislocation, swallowing difficulties (that may require tube feeding), brain anomalies (including cortical dysplasia and agenesis of the corpus callosum) and spasticity.
MONDO:0035122	definition		A rare genetic syndromic intellectual disability in which the cause of the disease is a variation in the GRIN2B gene. It is characterized by infantile or childhood onset of mild to profound developmental delay and intellectual disability in all affected individuals, as well as variable occurrence of epilepsy, autism spectrum disorder / behavioral issues, microcephaly, muscle tone abnormalities such as hypotonia and spasticity, dystonic, dyskinetic, or choreiform movement disorder, and cortical visual impairment. Brain MRI may reveal abnormal cortical development, hypoplastic corpus callosum, enlarged/dysplastic basal ganglia, and hippocampal dysplasia.
MONDO:0100503	definition	A neurodevelopmental disorder in which the cause of the disease is a mutation in the DPH5 gene, which is characterized by craniofacial dysmorphology, profound neurodevelopmental delay, multisystem abnormalities, and miscarriages.	
MONDO:0859295	definition		A neurodevelopmental disorder in which the cause of the disease is a mutation in the DPH5 gene. It is characterized by craniofacial dysmorphology, profound neurodevelopmental delay, multisystem abnormalities, and miscarriages.
MONDO:0700250	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the SURF1 gene.
MONDO:0700299	definition		Any Cushing syndrome due to macronodular adrenal hyperplasia in which the cause of the disease is a mutation in the KDM1A gene.
MONDO:0800149	definition	Any commonn variable immunodeficiency in which the cause of the disease is an autosomal recessive variation in the TNFS13 gene.	Any common variable immunodeficiency in which the cause of the disease is an autosomal recessive variation in the TNFSF13 gene.
MONDO:0800501	definition	A spectrum of conditions with varied degree of cognitive, language, behavioral, and motor regression associated with marked spike-wave activation in sleep. The regression is seen within weeks of the EEG pattern. This syndrome encompasses the previous syndromes epileptic encephalopathy with continuous spike-wave in sleep and atypical childhood epilepsy with centrotemporal spikes (also previously known as pseudo-Lennox syndrome and atypical benign partial epilepsy). Landau‚ÄìKleffner syndrome is a specific subtype of EE-SWAS, where regression affects mainly language, with an acquired auditory agnosia.	A rare epileptic encephalopathy of childhood characterized by seizures, an electroencephalographic (EEG) pattern of electrical status epilepticus in sleep (ESES) and neurocognitive regression in at least 2 domains of development. This syndrome encompasses the previous syndromes epileptic encephalopathy with continuous spike-wave in sleep and atypical childhood epilepsy with centrotemporal spikes (also previously known as pseudo-Lennox syndrome and atypical benign partial epilepsy).
MONDO:0859160	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX16 gene.
MONDO:0859321	definition		Any mitochondrial complex III deficiency in which the cause of the disease is a mutation in the UQCRH gene.
MONDO:0859520	definition		Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX11 gene.
MONDO:0958258	definition		A form of endogenous Cushing syndrome characterized by chronic over-secretion of cortisol due to a benign adrenal tumor that arises from the adrenal cortex.
MONDO:0971007	definition		A neuroocular syndrome caused by a mutation in PRR12 gene. It encompasses a broad spectrum of overlapping anomalies, with developmental delay or impaired intellectual development as a consistent finding. Eye abnormalities show marked variability in the type and severity of defects, and include anophthalmia, microphthalmia, and coloboma. Other common systemic features include congenital heart and kidney defects, hypotonia, failure to thrive, and microcephaly.
MONDO:0001389	obsoletion_candidate	True	
MONDO:0005259	obsoletion_candidate	True	
MONDO:0006518	obsoletion_candidate		True
MONDO:0007828	obsoletion_candidate	True	
MONDO:0800029	obsoletion_candidate		True
MONDO:0010061	obsoletion_candidate	True	
MONDO:0014453	obsoletion_candidate	True	
MONDO:0100028	obsoletion_candidate		True
MONDO:0018206	obsoletion_candidate	True	
MONDO:0018823	obsoletion_candidate	True	
MONDO:0018825	obsoletion_candidate	True	
MONDO:0019123	obsoletion_candidate		True
MONDO:0020522	obsoletion_candidate	True	
MONDO:0020732	obsoletion_candidate	True	
MONDO:0100503	obsoletion_candidate	True	
MONDO:0850090	obsoletion_candidate	True	
MONDO:0850416	obsoletion_candidate		True
MONDO:0859761	obsoletion_candidate	True	
MONDO:0859762	obsoletion_candidate	True	
MONDO:0957115	obsoletion_candidate	True	
MONDO:0001389	obsolete		True
MONDO:0005259	obsolete		True
MONDO:0007828	obsolete		True
MONDO:0010061	obsolete		True
MONDO:0018823	obsolete		True
MONDO:0018825	obsolete		True
MONDO:0020522	obsolete		True
MONDO:0020732	obsolete		True
MONDO:0100503	obsolete		True
MONDO:0850090	obsolete		True
MONDO:0859761	obsolete		True
MONDO:0859762	obsolete		True
MONDO:0957115	obsolete		True
